Immunogenicity of haemophilus influenzae Type b Conjugate Vaccines in Korean Infants: A Meta-analysis

Hyunju Lee, Seokyung Hahn, Hoan Jong Lee, Kyung Hyo Kim

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


A meta-analysis was performed on the immunogenicity of Haemophilus influenzae type b (Hib) conjugate vaccines after 2 (2 and 4 months) and 3 doses (2, 4, and 6 months) in Korean infants. A database search of MEDLINE, KoreaMed, and Korean Medical Database was done. The primary outcome measure was the proportion of infants with anti-polyribosylribitol phosphate (PRP) concentrations ≥1.0 mg/mL. Eight studies including eleven trials were retrieved. One trial reported on the diphtheria toxoid conjugate vaccine (PRP-D) and 2 trials each on the mutant diphtheria toxin (PRP-CRM) and Neisseria meningitidis outer-membrane protein (PRP-OMP) conjugate vaccine. Heterogeneity in study designs between trials on PRP-CRM was noted and one trial reported on a monovalent and another on a combination PRPOMP vaccine. Thus, a meta-analysis was conducted only on the tetanus toxoid conjugate vaccine (PRP-T). After a primary series of 2 doses and 3 doses, 80.6% (95% confidence interval [CI]; 76.0-85.1%) and 95.7% (95% CI; 94.0-98.0%) of infants achieved an antibody level ≥1.0 mg/mL, respectively. The immunogenic response to the PRP-T vaccine was acceptable after a primary series of 3 doses and also 2 doses. A reduced number of doses as a primary series could be carefully considered in Korean infants.

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalJournal of Korean Medical Science
Issue number1
StatePublished - Jan 2010


  • Haemophilus influenzae type b
  • Immunity
  • Meta-analysis
  • Vaccines


Dive into the research topics of 'Immunogenicity of haemophilus influenzae Type b Conjugate Vaccines in Korean Infants: A Meta-analysis'. Together they form a unique fingerprint.

Cite this